产品名称

BMS 204352, (R)-(-)-

产品货号

Axon 1309 CAS [187523-36-0] MF C16H10ClF4NO2MW 359.70 Purity: 98% Optical purity: >98% ee Soluble in DMSO Description Less active opposite R-(-)-enantiomer of S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), a Maxi-K channel opener References Certificates Categories Extra info Krishna R et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats. Biopharm Drug Dispos. 2002, 23(6), 233-7. M. P. G. Korsgaard et al. Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels. J. Pharmacol. Exp. Ther. 2005, 314, 282-292. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS KCa1.1 KCNMA1 Potassium channel opener; Less active enantiomer of Axon 1112 Chemical name (R)-3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No. [187523-36-0] Order Size Unit Price Stock 5 mg €145.00 In Stock

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

BMS 204352, (R)-(-)-

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1309

CAS [187523-36-0]

MF C16H10ClF4NO2
MW 359.70

Purity: 98%
Optical purity: >98% ee
Soluble in DMSO

BMS 204352, (R)-(-)-

Description

Less active opposite R-(-)-enantiomer of S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), a Maxi-K channel opener

Krishna R et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats. Biopharm Drug Dispos. 2002, 23(6), 233-7.

M. P. G. Korsgaard et al. Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels. J. Pharmacol. Exp. Ther. 2005, 314, 282-292.

Potassium channel opener; Less active enantiomer of Axon 1112

Chemical name

(R)-3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one

Parent CAS No.

[187523-36-0]

产品资料